-+ 0.00%
-+ 0.00%
-+ 0.00%

Whitehawk Therapeutics appoints former Incyte executive Vijay Iyengar to board

PUBT·09/10/2026 20:09:59
Listen to the news
Whitehawk Therapeutics appoints former Incyte executive Vijay Iyengar to board
  • Whitehawk Therapeutics appointed Vijay Iyengar to its board, effective Sept. 9, 2026.
  • Iyengar previously held senior leadership roles at Incyte, supporting five brand launches across eight indications and expansion into more than 20 countries.
  • He also held senior oncology leadership roles at Novartis, earlier serving as an engagement manager at McKinsey’s healthcare practice.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Whitehawk Therapeutics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202609101605PR_NEWS_USPR_____LA45157) on September 10, 2026, and is solely responsible for the information contained therein.